ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CYBG Ve Bionic Etf

16.968
-0.075 (-0.44%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Ve Bionic Etf LSE:CYBG London Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.075 -0.44% 16.968 16.874 17.064 17.076 16.957 17.076 219 16:35:09

CYBG PLC Directorate Change (5824T)

06/01/2017 3:38pm

UK Regulatory


Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ve Bionic Etf Charts.

TIDMCYBG TIDM11IO

RNS Number : 5824T

CYBG PLC

06 January 2017

CYBG PLC

(Company)

6 January 2017

Directorate Changes

The Company announces that Richard Gregory intends to retire as a Non-Executive Director on 10 January 2017. He will also retire as a Non-Executive Director of CYB Investments Limited and Clydesdale Bank PLC.

Richard joined the CYBG PLC group in March 2000 and is Senior Independent Non-Executive Director, Chair of the Board's Risk Committee, a member of the Board's Audit Committee and a member of the Board's Governance and Nomination Committee.

Jim Pettigrew, Chairman of the CYBG PLC Board said "On behalf of the Board I would like to thank Richard Gregory for his major contribution to the CYBG PLC group over a long period. Richard has been a very strong advocate of the Clydesdale and Yorkshire Bank brands during his extensive career and has brought considerable experience and insight to the Board. Richard played a key role in supporting the Board and management team during the Demerger from National Australia Bank Limited and the Initial Public Offering which was successfully completed last year. We wish him well for the future".

As a result of his retirement, Richard Gregory will not submit himself for re-election as a Director of the Company at the Company's Annual General Meeting on 31 January 2017 and resolution number 13 in the Notice of Annual General Meeting 2017 is therefore withdrawn.

David Bennett, Deputy Chairman will be appointed Senior Independent Non-Executive Director with effect from 11 January 2017. David joined the CYBG PLC group in October 2015. He is a member of the Board's Audit Committee, Board's Governance and Nomination Committee, Board's Risk Committee and Board's Remuneration Committee.

In addition, Clive Adamson will be appointed Chair of the Board's Risk Committee with effect 11 January 2017. Clive joined the CYBG PLC group in July 2016. He is a member of the Board's Audit Committee and Board's Risk Committee.

There are no other matters requiring disclosure under Listing Rule 9.6.13.

Enquiries

Investors and Analysts

John Crosse +44 7917 172535

Head of Investor Relations john.crosse@cybg.com

Hany Messieh +61 414 446 876

Investor Relations (Australia) hany.messieh@cybg.com

Company Secretary

Lorna McMillan 07834 585436

Company Secretary lorna.mcmillan@cybg.com

Media Relations

Press Office 0800 066 5998

press.office@cybg.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOABUGDBLXGBGRL

(END) Dow Jones Newswires

January 06, 2017 10:38 ET (15:38 GMT)

1 Year Ve Bionic Etf Chart

1 Year Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

Your Recent History

Delayed Upgrade Clock